» Articles » PMID: 24359982

Electrolyte Disorders Associated with Cancer

Overview
Specialty Nephrology
Date 2013 Dec 24
PMID 24359982
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with malignancies commonly experience abnormalities in serum electrolytes, including hyponatremia, hypokalemia, hyperkalemia, hypophosphatemia, and hypercalcemia. In many cases, the causes of these electolyte disturbances are due to common etiologies not unique to the underlying cancer. However, at other times, these electrolyte disorders signal the presence of paraneoplastic processes and portend a poor prognosis. Furthermore, the development of these electrolyte abnormalities may be associated with symptoms that can negatively affect quality of life and may prevent certain chemotherapeutic regimens. Thus, prompt recognition of these disorders and corrective therapy is critical in the care of the patient with cancer.

Citing Articles

Salivary Metabolites in Breast Cancer and Fibroadenomas: Focus on Menopausal Status and BMI.

Dyachenko E, Belskaya L Metabolites. 2024; 14(10).

PMID: 39452912 PMC: 11509358. DOI: 10.3390/metabo14100531.


Kidney care in patients with cancer: perspectives from the onconephrology committee of the Brazilian Society of Nephrology.

Brito G, Caires R, Coelho F, Campos M, Cunha D, Costalonga E Rev Assoc Med Bras (1992). 2024; 70(suppl 1):e2024S121.

PMID: 38865541 PMC: 11164260. DOI: 10.1590/1806-9282.2024S121.


Trans-thoracic versus trans-hiatal resection for oesophageal carcinoma: a retrospective comparative study of a single-centre case series.

Baram A, Sherzad H Cardiothorac Surg. 2024; 28(1):25.

PMID: 38624644 PMC: 7686938. DOI: 10.1186/s43057-020-00035-y.


Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis.

She X, Yin D, Guo Q, Tang Y, Wang S, Wang X Sci Rep. 2024; 14(1):5592.

PMID: 38454105 PMC: 10920770. DOI: 10.1038/s41598-024-56335-4.


Investigation of the Ability to Detect Electrolyte Disorder Using PET with Positron Annihilation Lifetime Spectroscopy.

Zaleski R, Kotowicz O, Gorska A, Zaleski K, Zgardzinska B J Phys Chem B. 2023; 127(46):9887-9890.

PMID: 37946359 PMC: 10683008. DOI: 10.1021/acs.jpcb.3c04208.